News brief
On 2026-06-10, according to Xiniu Data, Baiyingnuo completed Series A financing for an undisclosed amount. Investors were lead investor Hubei Shengchutianfengmingkechuangtianshi Investment Fund Partnership (Limited Partnership), participating investor Wuhan Wuchuangxinghuozhongmiao Venture Capital Fund Partnership (Limited Partnership), participating investor Caobenjinfangjiankang Technology (Guangdong) Co., Ltd., participating investor Zhuhai Hengqinbohuayixuejianyan Co., Ltd., participating investor Zhuhai Hengqinjinzhuang Venture Capital Fund (Limited Partnership). The company is a provider of precision diagnosis and treatment services using ultrasound brain-computer interfaces.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年6月10日，据烯牛数据报道，百英诺完成A轮融资，金额未披露。投资方为湖北省楚天凤鸣科创天使投资基金合伙企业（有限合伙）领投，武汉武创星火种苗创业投资基金合伙企业（有限合伙）、草本金方健康科技（广东）有限公司、珠海横琴铂华医学检验有限公司、珠海横琴金庄创业投资基金（有限合伙）跟投。该公司为超声脑机接口精准诊疗服务提供商。